Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS): Rationale and personal experience

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 71, Issue 2, 1997, Pages 135-139

  Cosmi, Ermelando V ^a   La Torre, Renato ^a   Piazze, Juan J ^a   Luca Maranghi, G ^a   Lerro, Niccolò ^a   Bianco, Domizia ^a   Anceschi, Maurizio M ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

aminophylline; fetal lung immaturity; intramniotic surfactant; IRDS; surfactant

Indexed keywords

AMINOPHYLLINE; SURFACTANT;

AMNION FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; FETUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; REGIONAL PERFUSION; RESPIRATORY DISTRESS SYNDROME; ULTRASOUND;

EID: 0031080795     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(96)02623-1     Document Type: Conference Paper

References (20)

1. [1] Crowley P, Chalmers I and Keirse MJN. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97: 11-25.
2. [2] Adams FH, Fujiwara T: Surfactant in the fetal lambs tracheal fluid. J Pediat 1963; 63: 537-542.
3. [3] Adams FH, Fujiwara T, Rowshan G: The nature and origin of the fluid in the fetal lamb lung. J Pediat 1963; 63: 881-888.
4. [4] Gluck L, Motoyama EK, Smits HL. Kulovich MV: The biochemical development of surface activity in mammalian lung. I. Pediat Res 1967; 1: 237-246.
5. [5] Gluck L, Scribney M, Kulovich MV. The biochemical development of surface activity in the mammalian. II. Pediat Res 1967; 1: 247-265.
6. [6] Scarpelli EM (Ed). The lung tracheal fluid, and lipid metabolism of the fetus. Pediatrics 1967; 40: 951-961.
7. [7] Scarpelli EM. The surfactant system of the lung. Philadelphia: Lea and Febiger, 1968.
8. [8] Gluck L, Kulovich MV, Borer RC Jr. Brenner PH, Anderson GG, Spellacy WN. Diagnosis of respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol 1971; 109: 440-445.
9. [9] Scarpelli EM: Intrapulmonary foam at birth: an adaptional phenomenon. Pediat Res 1978; 12: 1070-1080.
10. [10] Fujiwara T, Chida S, Watabe Y, Maeta H, Morita T, Abe T. Artificial surfactant therapy in hyaline membrane disease. Lancet 1980; 1: 155-59.
11. [11] Galan HL, Cipriani C, Coulson JJ, Bean JD, Collier G, Kuehl TJ. Surfactant replacement therapy in utero for the prevention of hyaline membrane disease in the preterm baboon. Am J Obstet Gynecol 1993; 169: 817-824.
12. [12] Galan HL, Cipriani C, Coalson JJ, Bean-Lijewski JD, Collier G, Kuhel TJ: Hyaline membrane disease surfactant prophylaxis in the preterm baboon: a comparison of postpartum versus in utero therapy. Prenat Neonat Med 1996; 1: 122-130.
13. [13] Petrikovsky BM, Lysikiewicz A, Markin LB, Slomko Z. In utero surfactant administration to preterm human fetuses by endoscopy. Fetal Diag Therap 1995; 10: 127-130.
14. [14] Scarpelli EM, Condorelli S, Cosmi EV. Fetal pulmonary fluid. I. Validation and significance of method for determination of volume and volume change. Pediatr Res 1975; 9: 190-95.
15. [15] Scarpelli EM, Condorelli S, Cosmi EV. Lamb Fetal Pulmonary Fluid. II Fate of phosphatidylcholine. Pediatr Res 1975; 9: 195-201.
16. [16] Cosmi EV, Felli F, Grossmann G, Lachmann B, Robertson B. Improved survival in the in the premature rabbit neonate following antenatal treatment with aminophylline. IRCS Med Sci 1979; 7: 115.
17. [17] Cosmi EV, La Torre R, Di Iorio R, Anceschi MM. A novel treatment of fetal lung immaturity. Society for Perinatal Obstetricians, 16th Annual Meeting. Am J Obstet Gynecol 1996; 174: 1 (2): 487 Abstract No. 653.
18. [18] Cosmi EV, La Torre R, Di Iorio R, Anceschi MM. Surfactant administration to the human fetus in utero: a new approach to prevention of neonatal respiratory distress syndrome (IRDS), J Perinat Med 1996; 24: 191-193.
19. [19] Cosmi EV, La Torre R, Di Iorio R. Intraamniotic instillation of surfactant for prevention of neonatal respiratory distress syndrome (IRDS): a preliminary report. Appl Cardiopulm Pathophysiol 1996; 6: 3-5.
20. [20] Cosmi EV. Prenatal administration of surfactant. Prenat Neonat Med 1996; 1: 109-111.